UNICA IRIS Institutional Research Information System

MUGHEDDU, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.670
NA - Nord America 1.399
AS - Asia 1.018
SA - Sud America 197
AF - Africa 31
OC - Oceania 1
Totale 18.316
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 15.288
US - Stati Uniti d'America 1.358
SG - Singapore 422
CN - Cina 293
BR - Brasile 153
SE - Svezia 121
VN - Vietnam 120
FR - Francia 54
DE - Germania 51
FI - Finlandia 48
BD - Bangladesh 38
GB - Regno Unito 33
HK - Hong Kong 29
CA - Canada 20
IN - India 18
ES - Italia 17
KR - Corea 16
MX - Messico 16
IQ - Iraq 15
AR - Argentina 13
NL - Olanda 13
EC - Ecuador 9
JP - Giappone 9
ZA - Sudafrica 9
IE - Irlanda 8
PK - Pakistan 8
PL - Polonia 8
CO - Colombia 7
ID - Indonesia 7
AT - Austria 6
AE - Emirati Arabi Uniti 5
EG - Egitto 5
UA - Ucraina 5
UZ - Uzbekistan 5
KE - Kenya 4
KZ - Kazakistan 4
MA - Marocco 4
PY - Paraguay 4
RU - Federazione Russa 4
SA - Arabia Saudita 4
TR - Turchia 4
VE - Venezuela 4
HU - Ungheria 3
JO - Giordania 3
NP - Nepal 3
PH - Filippine 3
AZ - Azerbaigian 2
BO - Bolivia 2
CH - Svizzera 2
CL - Cile 2
IR - Iran 2
JM - Giamaica 2
LV - Lettonia 2
MY - Malesia 2
NG - Nigeria 2
RO - Romania 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
TW - Taiwan 1
Totale 18.316
Salva come PNG Salva come JPEG
Città #
Cagliari 14.472
Uta 703
Singapore 239
Dallas 166
Ashburn 156
San Jose 118
Fairfield 96
Beijing 64
Boardman 60
Council Bluffs 59
Los Angeles 45
Ho Chi Minh City 44
Helsinki 40
Houston 40
Nyköping 38
Woodbridge 38
Chicago 36
Cambridge 29
Seattle 28
Wilmington 27
Hong Kong 26
Lauterbourg 26
The Dalles 26
Hanoi 25
Santa Clara 25
Hefei 24
Ann Arbor 15
Milan 15
Seoul 15
Shanghai 15
São Paulo 15
New York 14
Boston 13
Redwood City 13
Rome 13
Buffalo 12
Frankfurt am Main 12
Madrid 12
Elk Grove Village 11
London 11
Nuremberg 9
Redondo Beach 9
Salt Lake City 9
Dong Ket 8
Guangzhou 8
Brooklyn 7
Charlotte 7
Lappeenranta 7
Orem 7
San Diego 7
Toronto 7
Warsaw 7
Amsterdam 6
Baghdad 6
Da Nang 6
Hải Dương 6
Jacksonville 6
Miami 6
Munich 6
Nanjing 6
Shijiazhuang 6
Tampa 6
Esslingen am Neckar 5
Haiphong 5
Mountain View 5
Naples 5
Ninh Bình 5
Phoenix 5
Rio de Janeiro 5
Shenzhen 5
Belo Horizonte 4
Chandler 4
Chengdu 4
Denver 4
Düsseldorf 4
Johannesburg 4
Latina 4
Mexico City 4
Montreal 4
Mumbai 4
Nairobi 4
Paris 4
Senigallia 4
Sterling 4
Tashkent 4
Tianjin 4
Tokyo 4
Vancouver 4
Vienna 4
Almaty 3
Amman 3
Asunción 3
Atlanta 3
Bari 3
Barnet 3
Bexley 3
Brasília 3
Chennai 3
Dalian 3
Goiânia 3
Totale 17.137
Salva come PNG Salva come JPEG
Nome #
Psoriasis health care in the time of the coronavirus pandemic: insights from dedicated centers in sardinia (Italy) 2.287
Biologics exposure during pregnancy and breastfeeding in a psoriasis patient 1.552
Successful Guselkumab treatment in a psoriatic patient affected with Cornelia de Lange Syndrome, and prosecution during the COVID-19 pandemic 1.526
Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic 1.493
COVID-19 pulmonary infection in erythrodermic psoriatic patient with oligodendroglioma: safety and compatibility of apremilast with critical intensive care management 1.385
Erythrodermic psoriasis in a dialyzed patient successfully treated with Secukinumab 1.280
Safety of secukinumab treatment in COVID-19 affected psoriatic patients 1.022
Image Gallery: Green moss-like psoriasis 850
Patients' demographic and socioeconomic characteristics influence the therapeutic decision-making process in psoriasis 828
The Challenging Differentiation of Psoriatic Arthritis from Other Arthropathies and Nonspecific Arthralgias in Patients with Psoriasis: Results of a Cross-Sectional Rheumatologic Assessment of a Large Dermatologic Cohort 779
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 737
Secukinumab for the treatment of palmoplantar psoriasis: a 2-year, multicenter, real-life observational study 635
Do not forget about myasthenia gravis when performing botulinum toxin injections 599
Real-world outcomes in patients with moderate-to-severe plaque psoriasis treated with guselkumab for up to 1 year 594
Treatment of psoriasis with different classes of biologics reduces the likelihood of peripheral and axial psoriatic arthritis development 545
Multiple Orocutaneous Extraintestinal Manifestations in Ulcerative Colitis Patient: Complete Response to Ustekinumab 464
Dermoscopy of Tinea Incognito 441
Biologic anti-IL17 drugs in erythrodermic psoriasis 240
Long-Term Persistence Rate of Secukinumab in Psoriatic Patients: A Six-Year Multicenter, Real-World Experience, Retrospective Study 240
Rapid Efficacy of riSankizumab in pretibial psoriasis invOLVEment: RESOLVE 228
Real-world analysis of IL-23 inhibitors in patients with moderate-to-severe psoriasis and early musculoskeletal symptoms 178
Tinea Capitis Induced by Barber Shaving: Isolation of Trichophyton tonsurans 123
Efficacy of Calcipotriol/Betamethasone Ointment in Facial Discoid Dermatosis 108
Efficacy and Safety of Intra-Class Switching from Ixekizumab to Secukinumab in Patients with Plaque Psoriasis: A Multicenter Retrospective Study 100
Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index 96
The role of guselkumab in psoriatic artrithis and disease progression in patients with confirmed diagnosis of enthesitis 77
Totale 18.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.034
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.034
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021126 0 0 0 0 0 0 0 0 0 0 0 126
2021/20221.265 128 80 86 48 80 151 104 41 82 92 133 240
2022/20232.108 224 237 231 162 214 184 130 124 120 147 171 164
2023/20242.366 122 135 74 112 272 444 223 290 123 163 176 232
2024/20254.668 871 1.230 628 547 325 295 304 38 126 54 159 91
2025/20262.356 129 121 353 169 182 163 470 119 180 264 178 28
Totale 18.407